Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PG-11047 2HCl

😃Good
Catalog No. T73400L
Alias PG-11047 2HCl(949933-50-0 Free base), CGC-11047 2HCl

PG-11047 2HCl is an apoptosis-stimulating agent used in the treatment of genitourinary disorders, immune system disorders, genetic disorders and malformations, ocular disorders, and disorders of the blood and lymphatic systems, and in the study of lymphomas and prostate cancer.

PG-11047 2HCl

PG-11047 2HCl

😃Good
Purity: 99.51%
Catalog No. T73400LAlias PG-11047 2HCl(949933-50-0 Free base), CGC-11047 2HCl
PG-11047 2HCl is an apoptosis-stimulating agent used in the treatment of genitourinary disorders, immune system disorders, genetic disorders and malformations, ocular disorders, and disorders of the blood and lymphatic systems, and in the study of lymphomas and prostate cancer.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$67In StockIn Stock
5 mg$201In StockIn Stock
10 mg$322In StockIn Stock
25 mg$521In StockIn Stock
50 mg$755In StockIn Stock
100 mg$1,060In StockIn Stock
200 mg$1,430-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products. If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.51%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
PG-11047 2HCl is an apoptosis-stimulating agent used in the treatment of genitourinary disorders, immune system disorders, genetic disorders and malformations, ocular disorders, and disorders of the blood and lymphatic systems, and in the study of lymphomas and prostate cancer.
In vitro
PG-11047 2HCl (13 nM-5 mM; 72 h) inhibits the growth of members of a broad range of mammary cell lineages, with basal-like cell lines being inhibited at lower concentrations than luminal cell lines.[1]
PG-11047 2HCl (0.3, 10, 300 μM; 48 h, 72 h) shows a significant reduction in S-phase fraction at doses that produce little apoptosis.[1]
SynonymsPG-11047 2HCl(949933-50-0 Free base), CGC-11047 2HCl
Chemical Properties
Molecular Weight329.35
FormulaC14H34Cl2N4
SmilesCCNCCCNCC=CCNCCCNCC.Cl.Cl
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 4.62 mg/mL (14.03 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.0363 mL15.1814 mL30.3628 mL151.8142 mL
5 mM0.6073 mL3.0363 mL6.0726 mL30.3628 mL
10 mM0.3036 mL1.5181 mL3.0363 mL15.1814 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PG-11047 2HCl | purchase PG-11047 2HCl | PG-11047 2HCl cost | order PG-11047 2HCl | PG-11047 2HCl chemical structure | PG-11047 2HCl in vitro | PG-11047 2HCl formula | PG-11047 2HCl molecular weight